Heritability of insomnia symptoms in youth and their relationship to depression and anxiety

Department of Psychiatry & Penn Sleep Center, University of Pennsylvania, 3535 Market Street, Suite 670, Philadelphia, PA 19104, USA.
Sleep (Impact Factor: 4.59). 12/2011; 34(12):1641-6. DOI: 10.5665/sleep.1424
Source: PubMed

ABSTRACT Insomnia is a highly prevalent sleep disorder yet little is known about the role of genetic factors in its pathophysiology. The aim of this study was to examine the relative contributions of genetic and environmental factors in explaining variability in insomnia symptoms.
Traditional twin design.
Academic medical center.
1412 twin pairs aged 8-16 years (48.8% MZ, 47.2% DZ, 4.0% indeterminate).
Ratings of insomnia symptoms, depression, and overanxious disorder were made by trained interviewers based on DSM-III-R criteria. ACE models were conducted using Mx statistical software. Insomnia symptoms were prevalent in this sample based both on parental (6.6%) and youth (19.5%) reports. The overall heritability of insomnia symptoms was modest (30.7%), with the remaining variance attributed to unique environmental effects. There was no evidence of sex differences in the prevalence of insomnia symptoms or in the contribution of genetic and environmental effects. In multivariate models, there was support for insomnia-specific unique environmental effects over and above overlapping effects with depression and overanxious disorder, but no evidence for insomnia-specific genetic effects.
Genetic factors play a modest role in the etiology of insomnia symptoms in 8-16 year-olds. These effects overlap with the genetics of depression and overanxious disorder. Further work is needed to determine which genes confer risk for all three disorders.

Download full-text


Available from: Philip R Gehrman, Sep 26, 2015
1 Follower
24 Reads
  • Source
    • "Sleep disturbances are commonly observed in individuals with ASD, with prevalence estimates ranging from 50 to 80 % (Couturier et al. 2005; Krakowiak et al. 2008; Goldman et al. 2009; Souders et al. 2009). Current heritability estimates of sleep disruption indicate underlying genetic effects, with the proportion of variance in sleep problems related to heritable factors ranging from 20 to 64 % (Heath et al. 1990; Dauvilliers et al. 2005; Watson et al. 2006; Gehrman et al. 2011). Further, variation in genes whose products regulate endogenous melatonin modify sleep patterns in humans (Arendt 1998; Masana and Dubocovich 2001) and have been implicated in ASD (Cai et al. 2008; Melke et al. 2008; Hu et al. 2009; Jonsson et al. 2010; Braam et al. 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sleep disruption is common in individuals with autism spectrum disorder (ASD). Genes whose products regulate endogenous melatonin modify sleep patterns and have been implicated in ASD. Genetic factors likely contribute to comorbid expression of sleep disorders in ASD. We studied a clinically unique ASD subgroup, consisting solely of children with comorbid expression of sleep onset delay. We evaluated variation in two melatonin pathway genes, acetylserotonin O-methyltransferase (ASMT) and cytochrome P450 1A2 (CYP1A2). We observed higher frequencies than currently reported (p < 0.04) for variants evidenced to decrease ASMT expression and related to decreased CYP1A2 enzyme activity (p ≤ 0.0007). We detected a relationship between genotypes in ASMT and CYP1A2 (r(2) = 0.63). Our results indicate that expression of sleep onset delay relates to melatonin pathway genes.
    Journal of Autism and Developmental Disorders 07/2014; 45(1). DOI:10.1007/s10803-014-2197-4 · 3.34 Impact Factor
  • Source
    • "1042 Monozygotic 828 Dizygotic USA 57% Hublin et al., 2011 [54] 1554 Monozygotic 2991 Dizygotic Finnish Twin Cohort 46% 34% Early morning awakening 45% Nocturnal awakening German et al., 2011 [55] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sleep is a complex physiological process and still remains one of the great mysteries of science. Over the past 10 y, genetic research has provided a new avenue to address the regulation and function of sleep. Gene loci that contribute quantitatively to sleep characteristics and variability have already been identified. However, up to now, a genetic basis has been established only for a few sleep disorders. Little is yet known about the genetic background of insomnia, one of the most common sleep disorders. According to the conceptualisation of the 3P model of insomnia, predisposing, precipitating and perpetuating factors contribute to the development and maintenance of insomnia. Growing evidence from studies of predisposing factors suggests a certain degree of heritability for insomnia and for a reactivity of sleep patterns to stressful events, explaining the emergence of insomnia in response to stressful life events. While a genetic susceptibility may modulate the impact of stress on the brain, this finding does not provide us with a complete understanding of the capacity of stress to produce long-lasting perturbations of brain and behaviour. Epigenetic gene-environment interactions have been identified just recently and may provide a more complex understanding of the genetic control of sleep and its disorders. It was recently hypothesised that stress-response-related brain plasticity might be epigenetically controlled and, moreover, several epigenetic mechanisms have been assumed to be involved in the regulation of sleep. Hence, it might be postulated that insomnia may be influenced by an epigenetic control process of both sleep mechanisms and stress-response-related gene-environment interactions having an impact on brain plasticity. This paper reviews the evidence for the genetic basis of insomnia and recent theories about epigenetic mechanisms involved in both sleep regulation and brain-stress response, leading to the hypothesis of an involvement of epigenetic mechanisms in the development and maintenance of insomnia.
    Sleep Medicine Reviews 08/2013; 18(3). DOI:10.1016/j.smrv.2013.05.002 · 8.51 Impact Factor
  • Sleep Medicine 07/2012; 13(8):969-70. DOI:10.1016/j.sleep.2012.06.018 · 3.15 Impact Factor
Show more